ZA200804778B - New process for the preparation of esomeprazole non-salt form - Google Patents

New process for the preparation of esomeprazole non-salt form

Info

Publication number
ZA200804778B
ZA200804778B ZA200804778A ZA200804778A ZA200804778B ZA 200804778 B ZA200804778 B ZA 200804778B ZA 200804778 A ZA200804778 A ZA 200804778A ZA 200804778 A ZA200804778 A ZA 200804778A ZA 200804778 B ZA200804778 B ZA 200804778B
Authority
ZA
South Africa
Prior art keywords
preparation
salt form
new process
esomeprazole non
esomeprazole
Prior art date
Application number
ZA200804778A
Other languages
English (en)
Inventor
Bohlin Martin
Lindberg Per
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200804778B publication Critical patent/ZA200804778B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200804778A 2005-12-05 2008-06-02 New process for the preparation of esomeprazole non-salt form ZA200804778B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74229605P 2005-12-05 2005-12-05

Publications (1)

Publication Number Publication Date
ZA200804778B true ZA200804778B (en) 2009-06-24

Family

ID=38123162

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200804778A ZA200804778B (en) 2005-12-05 2008-06-02 New process for the preparation of esomeprazole non-salt form

Country Status (13)

Country Link
US (1) US8124779B2 (ko)
EP (1) EP1960384A4 (ko)
JP (1) JP2009518394A (ko)
KR (1) KR20080076924A (ko)
CN (1) CN101321746A (ko)
AU (1) AU2006323245B2 (ko)
BR (1) BRPI0619158A2 (ko)
CA (1) CA2631919A1 (ko)
IL (1) IL191547A0 (ko)
NO (1) NO20083028L (ko)
NZ (1) NZ568471A (ko)
WO (1) WO2007067128A1 (ko)
ZA (1) ZA200804778B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2345408A3 (en) 2010-01-08 2012-02-29 Dr. Reddy's Laboratories Ltd. Acid labile drug formulations
US9356980B2 (en) 2012-07-31 2016-05-31 At&T Intellectual Property I, L.P. Distributing communication of a data stream among multiple devices

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
GB9105031D0 (en) * 1991-03-09 1991-04-24 Fisons Plc Processing analytical reagents
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
CN1138534C (zh) 1994-07-08 2004-02-18 阿斯特拉曾尼卡有限公司 多单元片剂
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
SE510666C2 (sv) * 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
NZ336034A (en) 1996-12-20 2000-09-29 Byk Gulden Lomberg Chem Fab 3-nitro-imidazo[1,2-b]pyridazines substituted by alkylene-pyridine derivatives and medicaments
US6586259B1 (en) * 1999-11-15 2003-07-01 Pharmanetics Incorporated Platelet/leukocyte interaction assay and reagent therefor
EP1487426B1 (en) * 2002-03-04 2012-08-22 Sloan-kettering Institute For Cancer Research Methods of inducing terminal differentiation
AU2003278406A1 (en) * 2002-10-22 2004-05-13 Ranbaxy Laboratories Limited Amorphous form of esomeprazole salts
EP1485373A1 (en) 2003-02-05 2004-12-15 Teva Pharmaceutical Industries Limited Method of stabilizing lansoprazole
US20060247277A1 (en) 2003-02-28 2006-11-02 Yatendra Kumar Polymorphs of s-omeprazole
CN1197861C (zh) 2003-06-10 2005-04-20 中国科学院成都有机化学研究所 固态光学纯中性的s－（－）－和r－（+）－奥美拉唑的制备方法
EP1892306A3 (en) * 2003-10-06 2008-06-11 Bayer HealthCare AG Methods and kits for investigating cancer
WO2006009894A1 (en) * 2004-06-17 2006-01-26 Anazaohealth Corporation Stabilized and lyophilized radiopharmaceutical agents for destroying tumors
KR100641534B1 (ko) * 2005-07-28 2006-11-01 한미약품 주식회사 에스오메프라졸 및 그의 염의 제조방법
CN101305100A (zh) * 2005-09-19 2008-11-12 普雷姆德股份有限公司 液相半乳糖氧化酶希夫测定法
WO2007041868A1 (en) * 2005-10-14 2007-04-19 Institut De Cardiologie De Montreal Method for detecting a biomarker of oxidative stress in a biological sample
US7906293B2 (en) * 2007-04-09 2011-03-15 Abbott Laboratories Acridinium phenyl esters useful in the analysis of biological
US9207242B2 (en) * 2008-10-09 2015-12-08 The University Of Hong Kong Cadherin-17 as diagnostic marker and therapeutic target for liver cancer

Also Published As

Publication number Publication date
CA2631919A1 (en) 2007-06-14
AU2006323245A1 (en) 2007-06-14
EP1960384A4 (en) 2010-03-24
IL191547A0 (en) 2008-12-29
WO2007067128A1 (en) 2007-06-14
KR20080076924A (ko) 2008-08-20
US20080269297A1 (en) 2008-10-30
AU2006323245B2 (en) 2011-03-03
NZ568471A (en) 2010-09-30
NO20083028L (no) 2008-07-04
BRPI0619158A2 (pt) 2011-09-20
JP2009518394A (ja) 2009-05-07
US8124779B2 (en) 2012-02-28
CN101321746A (zh) 2008-12-10
EP1960384A1 (en) 2008-08-27

Similar Documents

Publication Publication Date Title
TWI449540B (en) Process for the production of an abuse-proofed dosage form
DK3872059T3 (en) Process for the preparation of 2,3,3,3 tetrahydrofluoropropene
ZA200804198B (en) Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides
HK1201822A1 (en) Process for the preparation of 5,6-dihydro-1h-pyridin-2-one compounds 56--1h--2-
EP1861408A4 (en) PROCESS FOR PRODUCING HYDROCHLOROSILANES
EP1940793A4 (en) METHOD FOR PRODUCING MONTELUCASTS
PL1844036T3 (pl) Sposób otrzymywania arypiprazolu
ZA200804264B (en) Process for the preparation of ferri-succinylcasein
EP1874948A4 (en) PROCESS FOR THE PREPARATION OF Y-GLUTAMYLCYSTEIN
EG25547A (en) Process for the preparation of amines
ZA200601910B (en) Process for the preparation of organosilances
IL184715A0 (en) Process for the preparation of intermediates
GB2436262B (en) Process for the preparation of pantoprazole sodium
EP2024369A4 (en) NEW PROCESS FOR THE PREPARATION OF SILDENAFIL CITRATE
IL185335A0 (en) Process for the preparation of substituted benzoxazole compounds
PT1937662E (pt) Processo para a preparação de duloxetina
EP1917231A4 (en) PROCESS FOR THE PREPARATION OF BROMOPICRIN
EP1996192A4 (en) PROCESS FOR PREPARING 3,4-SUBSTITUTED THIAZOLIDIN-2-ONES IN 3,4
PL1928883T3 (pl) Sposób otrzymywania chlorowodorku irynotekanu
ZA200804778B (en) New process for the preparation of esomeprazole non-salt form
IL178960A0 (en) Process for the preparation of pyridin-2-ylmethylsulphinyl-1h-benzimidazol compounds
HU0401379D0 (en) Process for the preparation of risperidon
IL178237A0 (en) Process for the preparation of rosiglitazone
HUP0500570A3 (en) Process for the preparation of (s)-(-)-amlodipine
SI1732916T1 (sl) Postopek za pripravo alkoksikarbonilmetoksi-ciklopentanov